nodes	percent_of_prediction	percent_of_DWPC	metapath
Theophylline—HDAC2—Lovastatin—atherosclerosis	0.36	0.5	CbGbCtD
Theophylline—SLC22A7—Pravastatin—atherosclerosis	0.09	0.125	CbGbCtD
Theophylline—CYP2C8—Simvastatin—atherosclerosis	0.0257	0.0357	CbGbCtD
Theophylline—CYP2C8—Lovastatin—atherosclerosis	0.0252	0.0349	CbGbCtD
Theophylline—CYP2C8—Pravastatin—atherosclerosis	0.0252	0.0349	CbGbCtD
Theophylline—CYP2D6—Niacin—atherosclerosis	0.0208	0.0288	CbGbCtD
Theophylline—CYP2C9—Rosuvastatin—atherosclerosis	0.0193	0.0268	CbGbCtD
Theophylline—CYP2C9—Simvastatin—atherosclerosis	0.0179	0.0249	CbGbCtD
Theophylline—CYP2C9—Lovastatin—atherosclerosis	0.0176	0.0243	CbGbCtD
Theophylline—CYP2C9—Pravastatin—atherosclerosis	0.0176	0.0243	CbGbCtD
Theophylline—CYP2D6—Simvastatin—atherosclerosis	0.0164	0.0228	CbGbCtD
Theophylline—CYP2D6—Pravastatin—atherosclerosis	0.0161	0.0223	CbGbCtD
Theophylline—CYP2D6—Lovastatin—atherosclerosis	0.0161	0.0223	CbGbCtD
Theophylline—CYP3A4—Rosuvastatin—atherosclerosis	0.0112	0.0156	CbGbCtD
Theophylline—CYP3A4—Ezetimibe—atherosclerosis	0.0112	0.0156	CbGbCtD
Theophylline—CYP3A4—Simvastatin—atherosclerosis	0.0104	0.0145	CbGbCtD
Theophylline—CYP3A4—Pravastatin—atherosclerosis	0.0102	0.0142	CbGbCtD
Theophylline—CYP3A4—Lovastatin—atherosclerosis	0.0102	0.0142	CbGbCtD
Theophylline—PDE5A—penis—atherosclerosis	0.00653	0.118	CbGeAlD
Theophylline—PDE3A—penis—atherosclerosis	0.00636	0.115	CbGeAlD
Theophylline—PDE5A—artery—atherosclerosis	0.00302	0.0546	CbGeAlD
Theophylline—PDE5A—endothelium—atherosclerosis	0.00255	0.0461	CbGeAlD
Theophylline—PDE5A—blood vessel—atherosclerosis	0.00236	0.0425	CbGeAlD
Theophylline—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.00217	0.0254	CcSEcCtD
Theophylline—Peptic ulcer—Niacin—atherosclerosis	0.00209	0.0245	CcSEcCtD
Theophylline—PDE3B—connective tissue—atherosclerosis	0.00192	0.0347	CbGeAlD
Theophylline—Rhabdomyolysis—Lovastatin—atherosclerosis	0.00184	0.0215	CcSEcCtD
Theophylline—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.0018	0.0211	CcSEcCtD
Theophylline—Gastrooesophageal reflux disease—Ezetimibe—atherosclerosis	0.00176	0.0207	CcSEcCtD
Theophylline—Rhabdomyolysis—Simvastatin—atherosclerosis	0.00172	0.0201	CcSEcCtD
Theophylline—PDE3B—cardiovascular system—atherosclerosis	0.00167	0.0302	CbGeAlD
Theophylline—Rhabdomyolysis—Niacin—atherosclerosis	0.00158	0.0185	CcSEcCtD
Theophylline—Rhabdomyolysis—Pravastatin—atherosclerosis	0.00155	0.0182	CcSEcCtD
Theophylline—Hyperuricaemia—Niacin—atherosclerosis	0.0015	0.0176	CcSEcCtD
Theophylline—PDE3B—adipose tissue—atherosclerosis	0.00148	0.0266	CbGeAlD
Theophylline—ADA—connective tissue—atherosclerosis	0.00146	0.0263	CbGeAlD
Theophylline—Blood uric acid increased—Niacin—atherosclerosis	0.00142	0.0166	CcSEcCtD
Theophylline—Dermatitis contact—Niacin—atherosclerosis	0.00138	0.0162	CcSEcCtD
Theophylline—ADA—cardiovascular system—atherosclerosis	0.00127	0.0229	CbGeAlD
Theophylline—PDE4D—adipose tissue—atherosclerosis	0.00123	0.0222	CbGeAlD
Theophylline—ADORA2B—adipose tissue—atherosclerosis	0.00122	0.0221	CbGeAlD
Theophylline—PDE5A—connective tissue—atherosclerosis	0.00121	0.0218	CbGeAlD
Theophylline—HDAC2—Lovastatin—Pravastatin—atherosclerosis	0.0012	0.222	CbGdCrCtD
Theophylline—HDAC2—Lovastatin—Simvastatin—atherosclerosis	0.0012	0.222	CbGdCrCtD
Theophylline—Atrial fibrillation—Simvastatin—atherosclerosis	0.00116	0.0136	CcSEcCtD
Theophylline—ADORA2A—cardiovascular system—atherosclerosis	0.00115	0.0208	CbGeAlD
Theophylline—Polyuria—Niacin—atherosclerosis	0.00115	0.0135	CcSEcCtD
Theophylline—HDAC2—connective tissue—atherosclerosis	0.00113	0.0204	CbGeAlD
Theophylline—ADA—adipose tissue—atherosclerosis	0.00112	0.0202	CbGeAlD
Theophylline—PDE4A—adipose tissue—atherosclerosis	0.00109	0.0197	CbGeAlD
Theophylline—Atrial fibrillation—Niacin—atherosclerosis	0.00107	0.0125	CcSEcCtD
Theophylline—PDE5A—cardiovascular system—atherosclerosis	0.00105	0.019	CbGeAlD
Theophylline—PDE3B—liver—atherosclerosis	0.00104	0.0187	CbGeAlD
Theophylline—HDAC2—Fluvastatin—Rosuvastatin—atherosclerosis	0.00103	0.191	CbGdCrCtD
Theophylline—Haematuria—Rosuvastatin—atherosclerosis	0.00102	0.012	CcSEcCtD
Theophylline—PDE3A—cardiovascular system—atherosclerosis	0.00102	0.0185	CbGeAlD
Theophylline—ADORA1—cardiovascular system—atherosclerosis	0.000996	0.018	CbGeAlD
Theophylline—HDAC2—cardiovascular system—atherosclerosis	0.000984	0.0178	CbGeAlD
Theophylline—HDAC2—Simvastatin—Pravastatin—atherosclerosis	0.000984	0.182	CbGdCrCtD
Theophylline—HDAC2—Simvastatin—Lovastatin—atherosclerosis	0.000984	0.182	CbGdCrCtD
Theophylline—Urinary retention—Niacin—atherosclerosis	0.000963	0.0113	CcSEcCtD
Theophylline—PDE5A—adipose tissue—atherosclerosis	0.000927	0.0167	CbGeAlD
Theophylline—PDE3A—adipose tissue—atherosclerosis	0.000902	0.0163	CbGeAlD
Theophylline—ADORA1—adipose tissue—atherosclerosis	0.000879	0.0159	CbGeAlD
Theophylline—HDAC2—adipose tissue—atherosclerosis	0.000868	0.0157	CbGeAlD
Theophylline—PDE4D—liver—atherosclerosis	0.000864	0.0156	CbGeAlD
Theophylline—Arrhythmia—Rosuvastatin—atherosclerosis	0.00086	0.0101	CcSEcCtD
Theophylline—Flushing—Lovastatin—atherosclerosis	0.000757	0.00887	CcSEcCtD
Theophylline—Flushing—Ezetimibe—atherosclerosis	0.000743	0.0087	CcSEcCtD
Theophylline—CYP1B1—connective tissue—atherosclerosis	0.000726	0.0131	CbGeAlD
Theophylline—Alopecia—Lovastatin—atherosclerosis	0.000721	0.00845	CcSEcCtD
Theophylline—ADORA2A—liver—atherosclerosis	0.000714	0.0129	CbGeAlD
Theophylline—Flushing—Simvastatin—atherosclerosis	0.000708	0.0083	CcSEcCtD
Theophylline—SLC22A7—liver—atherosclerosis	0.000707	0.0128	CbGeAlD
Theophylline—Alopecia—Ezetimibe—atherosclerosis	0.000707	0.00829	CcSEcCtD
Theophylline—Infection—Rosuvastatin—atherosclerosis	0.00068	0.00796	CcSEcCtD
Theophylline—Alopecia—Simvastatin—atherosclerosis	0.000674	0.0079	CcSEcCtD
Theophylline—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000671	0.00786	CcSEcCtD
Theophylline—Tremor—Lovastatin—atherosclerosis	0.000666	0.0078	CcSEcCtD
Theophylline—Flushing—Niacin—atherosclerosis	0.00065	0.00762	CcSEcCtD
Theophylline—PDE4B—adipose tissue—atherosclerosis	0.00065	0.0117	CbGeAlD
Theophylline—Flushing—Pravastatin—atherosclerosis	0.00064	0.0075	CcSEcCtD
Theophylline—PDE3A—liver—atherosclerosis	0.000632	0.0114	CbGeAlD
Theophylline—CYP1B1—cardiovascular system—atherosclerosis	0.000632	0.0114	CbGeAlD
Theophylline—Arrhythmia—Niacin—atherosclerosis	0.000626	0.00733	CcSEcCtD
Theophylline—Tremor—Simvastatin—atherosclerosis	0.000623	0.00729	CcSEcCtD
Theophylline—Alopecia—Niacin—atherosclerosis	0.000619	0.00726	CcSEcCtD
Theophylline—Insomnia—Rosuvastatin—atherosclerosis	0.000619	0.00725	CcSEcCtD
Theophylline—Arrhythmia—Pravastatin—atherosclerosis	0.000616	0.00722	CcSEcCtD
Theophylline—Palpitations—Ezetimibe—atherosclerosis	0.000616	0.00721	CcSEcCtD
Theophylline—Alopecia—Pravastatin—atherosclerosis	0.00061	0.00714	CcSEcCtD
Theophylline—HDAC2—liver—atherosclerosis	0.000609	0.011	CbGeAlD
Theophylline—Anxiety—Lovastatin—atherosclerosis	0.000603	0.00706	CcSEcCtD
Theophylline—Tension—Niacin—atherosclerosis	0.000599	0.00701	CcSEcCtD
Theophylline—Nervousness—Niacin—atherosclerosis	0.000593	0.00694	CcSEcCtD
Theophylline—Tension—Pravastatin—atherosclerosis	0.000589	0.00691	CcSEcCtD
Theophylline—Nervousness—Pravastatin—atherosclerosis	0.000583	0.00683	CcSEcCtD
Theophylline—Anaphylactic shock—Lovastatin—atherosclerosis	0.00058	0.00679	CcSEcCtD
Theophylline—Infection—Lovastatin—atherosclerosis	0.000576	0.00675	CcSEcCtD
Theophylline—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000569	0.00666	CcSEcCtD
Theophylline—Infection—Ezetimibe—atherosclerosis	0.000565	0.00662	CcSEcCtD
Theophylline—Anxiety—Simvastatin—atherosclerosis	0.000564	0.0066	CcSEcCtD
Theophylline—Tremor—Pravastatin—atherosclerosis	0.000563	0.00659	CcSEcCtD
Theophylline—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000559	0.00655	CcSEcCtD
Theophylline—Nervous system disorder—Ezetimibe—atherosclerosis	0.000558	0.00653	CcSEcCtD
Theophylline—CYP1B1—adipose tissue—atherosclerosis	0.000557	0.0101	CbGeAlD
Theophylline—Anorexia—Lovastatin—atherosclerosis	0.000553	0.00647	CcSEcCtD
Theophylline—Urticaria—Rosuvastatin—atherosclerosis	0.000543	0.00637	CcSEcCtD
Theophylline—Anaphylactic shock—Simvastatin—atherosclerosis	0.000542	0.00635	CcSEcCtD
Theophylline—Abdominal pain—Rosuvastatin—atherosclerosis	0.000541	0.00634	CcSEcCtD
Theophylline—Palpitations—Niacin—atherosclerosis	0.000539	0.00632	CcSEcCtD
Theophylline—Infection—Simvastatin—atherosclerosis	0.000539	0.00631	CcSEcCtD
Theophylline—Insomnia—Lovastatin—atherosclerosis	0.000524	0.00614	CcSEcCtD
Theophylline—Anorexia—Simvastatin—atherosclerosis	0.000517	0.00606	CcSEcCtD
Theophylline—Insomnia—Ezetimibe—atherosclerosis	0.000514	0.00602	CcSEcCtD
Theophylline—Anxiety—Pravastatin—atherosclerosis	0.00051	0.00597	CcSEcCtD
Theophylline—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000504	0.0059	CcSEcCtD
Theophylline—Decreased appetite—Lovastatin—atherosclerosis	0.000504	0.0059	CcSEcCtD
Theophylline—Anaphylactic shock—Niacin—atherosclerosis	0.000498	0.00583	CcSEcCtD
Theophylline—Decreased appetite—Ezetimibe—atherosclerosis	0.000494	0.00579	CcSEcCtD
Theophylline—Insomnia—Simvastatin—atherosclerosis	0.00049	0.00575	CcSEcCtD
Theophylline—Anaphylactic shock—Pravastatin—atherosclerosis	0.00049	0.00574	CcSEcCtD
Theophylline—Shock—Niacin—atherosclerosis	0.00049	0.00574	CcSEcCtD
Theophylline—Infection—Pravastatin—atherosclerosis	0.000487	0.00571	CcSEcCtD
Theophylline—Tachycardia—Niacin—atherosclerosis	0.000486	0.00569	CcSEcCtD
Theophylline—Pruritus—Rosuvastatin—atherosclerosis	0.000484	0.00567	CcSEcCtD
Theophylline—Anorexia—Niacin—atherosclerosis	0.000475	0.00556	CcSEcCtD
Theophylline—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000474	0.00555	CcSEcCtD
Theophylline—Decreased appetite—Simvastatin—atherosclerosis	0.000471	0.00552	CcSEcCtD
Theophylline—Diarrhoea—Rosuvastatin—atherosclerosis	0.000468	0.00548	CcSEcCtD
Theophylline—Anorexia—Pravastatin—atherosclerosis	0.000467	0.00547	CcSEcCtD
Theophylline—Hypotension—Niacin—atherosclerosis	0.000465	0.00545	CcSEcCtD
Theophylline—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000465	0.00545	CcSEcCtD
Theophylline—Urticaria—Lovastatin—atherosclerosis	0.000461	0.0054	CcSEcCtD
Theophylline—Body temperature increased—Lovastatin—atherosclerosis	0.000458	0.00537	CcSEcCtD
Theophylline—Abdominal pain—Lovastatin—atherosclerosis	0.000458	0.00537	CcSEcCtD
Theophylline—PDE4B—liver—atherosclerosis	0.000456	0.00823	CbGeAlD
Theophylline—Dizziness—Rosuvastatin—atherosclerosis	0.000452	0.0053	CcSEcCtD
Theophylline—Urticaria—Ezetimibe—atherosclerosis	0.000452	0.00529	CcSEcCtD
Theophylline—Insomnia—Niacin—atherosclerosis	0.00045	0.00528	CcSEcCtD
Theophylline—Abdominal pain—Ezetimibe—atherosclerosis	0.00045	0.00527	CcSEcCtD
Theophylline—Body temperature increased—Ezetimibe—atherosclerosis	0.00045	0.00527	CcSEcCtD
Theophylline—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000443	0.00519	CcSEcCtD
Theophylline—Insomnia—Pravastatin—atherosclerosis	0.000443	0.00519	CcSEcCtD
Theophylline—Decreased appetite—Niacin—atherosclerosis	0.000433	0.00507	CcSEcCtD
Theophylline—Rash—Rosuvastatin—atherosclerosis	0.000431	0.00505	CcSEcCtD
Theophylline—Dermatitis—Rosuvastatin—atherosclerosis	0.000431	0.00505	CcSEcCtD
Theophylline—Urticaria—Simvastatin—atherosclerosis	0.000431	0.00505	CcSEcCtD
Theophylline—CYP2C9—cardiovascular system—atherosclerosis	0.00043	0.00776	CbGeAlD
Theophylline—Abdominal pain—Simvastatin—atherosclerosis	0.000429	0.00502	CcSEcCtD
Theophylline—Body temperature increased—Simvastatin—atherosclerosis	0.000429	0.00502	CcSEcCtD
Theophylline—Headache—Rosuvastatin—atherosclerosis	0.000429	0.00502	CcSEcCtD
Theophylline—Hypersensitivity—Lovastatin—atherosclerosis	0.000427	0.005	CcSEcCtD
Theophylline—Decreased appetite—Pravastatin—atherosclerosis	0.000426	0.00499	CcSEcCtD
Theophylline—Hypersensitivity—Ezetimibe—atherosclerosis	0.000419	0.00491	CcSEcCtD
Theophylline—Pruritus—Lovastatin—atherosclerosis	0.00041	0.0048	CcSEcCtD
Theophylline—CYP2E1—cardiovascular system—atherosclerosis	0.000407	0.00735	CbGeAlD
Theophylline—Gastrointestinal pain—Niacin—atherosclerosis	0.000407	0.00477	CcSEcCtD
Theophylline—Nausea—Rosuvastatin—atherosclerosis	0.000406	0.00476	CcSEcCtD
Theophylline—Pruritus—Ezetimibe—atherosclerosis	0.000402	0.00471	CcSEcCtD
Theophylline—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000401	0.0047	CcSEcCtD
Theophylline—Hypersensitivity—Simvastatin—atherosclerosis	0.0004	0.00468	CcSEcCtD
Theophylline—Diarrhoea—Lovastatin—atherosclerosis	0.000397	0.00465	CcSEcCtD
Theophylline—Urticaria—Niacin—atherosclerosis	0.000396	0.00463	CcSEcCtD
Theophylline—CYP1A1—adipose tissue—atherosclerosis	0.000394	0.00711	CbGeAlD
Theophylline—Abdominal pain—Niacin—atherosclerosis	0.000394	0.00461	CcSEcCtD
Theophylline—Body temperature increased—Niacin—atherosclerosis	0.000394	0.00461	CcSEcCtD
Theophylline—CYP1B1—liver—atherosclerosis	0.000391	0.00705	CbGeAlD
Theophylline—Urticaria—Pravastatin—atherosclerosis	0.000389	0.00456	CcSEcCtD
Theophylline—Diarrhoea—Ezetimibe—atherosclerosis	0.000389	0.00456	CcSEcCtD
Theophylline—Body temperature increased—Pravastatin—atherosclerosis	0.000388	0.00454	CcSEcCtD
Theophylline—Abdominal pain—Pravastatin—atherosclerosis	0.000388	0.00454	CcSEcCtD
Theophylline—Pruritus—Simvastatin—atherosclerosis	0.000384	0.00449	CcSEcCtD
Theophylline—Dizziness—Lovastatin—atherosclerosis	0.000383	0.00449	CcSEcCtD
Theophylline—Dizziness—Ezetimibe—atherosclerosis	0.000376	0.0044	CcSEcCtD
Theophylline—Diarrhoea—Simvastatin—atherosclerosis	0.000371	0.00435	CcSEcCtD
Theophylline—Vomiting—Lovastatin—atherosclerosis	0.000369	0.00432	CcSEcCtD
Theophylline—Hypersensitivity—Niacin—atherosclerosis	0.000367	0.0043	CcSEcCtD
Theophylline—Rash—Lovastatin—atherosclerosis	0.000366	0.00428	CcSEcCtD
Theophylline—Dermatitis—Lovastatin—atherosclerosis	0.000365	0.00428	CcSEcCtD
Theophylline—Headache—Lovastatin—atherosclerosis	0.000363	0.00425	CcSEcCtD
Theophylline—Vomiting—Ezetimibe—atherosclerosis	0.000362	0.00424	CcSEcCtD
Theophylline—Hypersensitivity—Pravastatin—atherosclerosis	0.000361	0.00423	CcSEcCtD
Theophylline—Dizziness—Simvastatin—atherosclerosis	0.000359	0.0042	CcSEcCtD
Theophylline—Rash—Ezetimibe—atherosclerosis	0.000359	0.0042	CcSEcCtD
Theophylline—Dermatitis—Ezetimibe—atherosclerosis	0.000358	0.0042	CcSEcCtD
Theophylline—Headache—Ezetimibe—atherosclerosis	0.000356	0.00417	CcSEcCtD
Theophylline—Pruritus—Niacin—atherosclerosis	0.000352	0.00413	CcSEcCtD
Theophylline—Pruritus—Pravastatin—atherosclerosis	0.000347	0.00406	CcSEcCtD
Theophylline—Vomiting—Simvastatin—atherosclerosis	0.000345	0.00404	CcSEcCtD
Theophylline—Nausea—Lovastatin—atherosclerosis	0.000344	0.00403	CcSEcCtD
Theophylline—Rash—Simvastatin—atherosclerosis	0.000342	0.00401	CcSEcCtD
Theophylline—Dermatitis—Simvastatin—atherosclerosis	0.000342	0.004	CcSEcCtD
Theophylline—Diarrhoea—Niacin—atherosclerosis	0.000341	0.00399	CcSEcCtD
Theophylline—Headache—Simvastatin—atherosclerosis	0.00034	0.00398	CcSEcCtD
Theophylline—Nausea—Ezetimibe—atherosclerosis	0.000338	0.00396	CcSEcCtD
Theophylline—Diarrhoea—Pravastatin—atherosclerosis	0.000335	0.00393	CcSEcCtD
Theophylline—Dizziness—Niacin—atherosclerosis	0.000329	0.00386	CcSEcCtD
Theophylline—Dizziness—Pravastatin—atherosclerosis	0.000324	0.0038	CcSEcCtD
Theophylline—Nausea—Simvastatin—atherosclerosis	0.000322	0.00377	CcSEcCtD
Theophylline—Vomiting—Niacin—atherosclerosis	0.000317	0.00371	CcSEcCtD
Theophylline—Rash—Niacin—atherosclerosis	0.000314	0.00368	CcSEcCtD
Theophylline—Dermatitis—Niacin—atherosclerosis	0.000314	0.00367	CcSEcCtD
Theophylline—Headache—Niacin—atherosclerosis	0.000312	0.00365	CcSEcCtD
Theophylline—Vomiting—Pravastatin—atherosclerosis	0.000312	0.00365	CcSEcCtD
Theophylline—Rash—Pravastatin—atherosclerosis	0.000309	0.00362	CcSEcCtD
Theophylline—Dermatitis—Pravastatin—atherosclerosis	0.000309	0.00362	CcSEcCtD
Theophylline—Headache—Pravastatin—atherosclerosis	0.000307	0.0036	CcSEcCtD
Theophylline—CYP2C8—liver—atherosclerosis	0.000299	0.0054	CbGeAlD
Theophylline—Nausea—Niacin—atherosclerosis	0.000296	0.00346	CcSEcCtD
Theophylline—Nausea—Pravastatin—atherosclerosis	0.000291	0.00341	CcSEcCtD
Theophylline—CYP1A2—liver—atherosclerosis	0.00028	0.00505	CbGeAlD
Theophylline—CYP1A1—liver—atherosclerosis	0.000276	0.00499	CbGeAlD
Theophylline—CYP2C9—liver—atherosclerosis	0.000266	0.0048	CbGeAlD
Theophylline—CYP2E1—liver—atherosclerosis	0.000252	0.00455	CbGeAlD
Theophylline—CYP3A4—liver—atherosclerosis	0.000203	0.00366	CbGeAlD
Theophylline—CYP2D6—liver—atherosclerosis	0.000199	0.0036	CbGeAlD
Theophylline—PDE4B—Signaling Pathways—MAPK8—atherosclerosis	7.57e-06	5.71e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—VEGFA—atherosclerosis	7.55e-06	5.7e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling by GPCR—AKT1—atherosclerosis	7.55e-06	5.7e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	7.54e-06	5.69e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—MAPK3—atherosclerosis	7.51e-06	5.66e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—STAT3—atherosclerosis	7.48e-06	5.64e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CETP—atherosclerosis	7.48e-06	5.64e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	7.47e-06	5.64e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	7.45e-06	5.62e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PPARG—atherosclerosis	7.45e-06	5.62e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	7.43e-06	5.61e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CETP—atherosclerosis	7.41e-06	5.59e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—TGFB1—atherosclerosis	7.4e-06	5.59e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALOX5—atherosclerosis	7.37e-06	5.56e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—VEGFA—atherosclerosis	7.35e-06	5.54e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ABCA1—atherosclerosis	7.34e-06	5.54e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—INS—atherosclerosis	7.31e-06	5.51e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—HMOX1—atherosclerosis	7.29e-06	5.5e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—TGFB1—atherosclerosis	7.28e-06	5.5e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—STAT3—atherosclerosis	7.28e-06	5.49e-05	CbGpPWpGaD
Theophylline—ADA—Metabolism—AKT1—atherosclerosis	7.26e-06	5.47e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—CXCL8—atherosclerosis	7.23e-06	5.46e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—SCARB1—atherosclerosis	7.16e-06	5.4e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—MAPK3—atherosclerosis	7.15e-06	5.39e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—SCARB1—atherosclerosis	7.1e-06	5.36e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—VEGFA—atherosclerosis	7.07e-06	5.34e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CYP27A1—atherosclerosis	7.05e-06	5.32e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—STAT3—atherosclerosis	7e-06	5.28e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—VEGFA—atherosclerosis	6.99e-06	5.27e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOB—atherosclerosis	6.98e-06	5.27e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—MAPK3—atherosclerosis	6.95e-06	5.24e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—TGFB1—atherosclerosis	6.93e-06	5.23e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—STAT3—atherosclerosis	6.92e-06	5.22e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.91e-06	5.21e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—HMOX1—atherosclerosis	6.87e-06	5.18e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	6.81e-06	5.13e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GSTM1—atherosclerosis	6.79e-06	5.12e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HMGCR—atherosclerosis	6.76e-06	5.1e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—TGFB1—atherosclerosis	6.74e-06	5.09e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—CXCL8—atherosclerosis	6.72e-06	5.07e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HMGCR—atherosclerosis	6.7e-06	5.06e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—ALB—atherosclerosis	6.7e-06	5.05e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—MAPK3—atherosclerosis	6.69e-06	5.05e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	6.69e-06	5.04e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOA2—atherosclerosis	6.69e-06	5.04e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALOX15—atherosclerosis	6.69e-06	5.04e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	6.69e-06	5.04e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—LPL—atherosclerosis	6.66e-06	5.03e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—MAPK3—atherosclerosis	6.61e-06	4.99e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NAMPT—atherosclerosis	6.61e-06	4.98e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCG5—atherosclerosis	6.6e-06	4.98e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOB—atherosclerosis	6.58e-06	4.96e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.57e-06	4.96e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—LIPC—atherosclerosis	6.57e-06	4.95e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MMP9—atherosclerosis	6.54e-06	4.94e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOC3—atherosclerosis	6.52e-06	4.92e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—GPX1—atherosclerosis	6.5e-06	4.91e-05	CbGpPWpGaD
Theophylline—ADORA2A—GPCR downstream signaling—AKT1—atherosclerosis	6.5e-06	4.9e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—TGFB1—atherosclerosis	6.49e-06	4.9e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—LDLR—atherosclerosis	6.48e-06	4.89e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—NFKB1—atherosclerosis	6.47e-06	4.88e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—TGFB1—atherosclerosis	6.41e-06	4.84e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—NOS3—atherosclerosis	6.41e-06	4.83e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GSTM1—atherosclerosis	6.4e-06	4.83e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—IL6—atherosclerosis	6.39e-06	4.82e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—LPA—atherosclerosis	6.38e-06	4.81e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK8—atherosclerosis	6.36e-06	4.8e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CETP—atherosclerosis	6.33e-06	4.78e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CD36—atherosclerosis	6.33e-06	4.78e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—IL6—atherosclerosis	6.3e-06	4.76e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—HMOX1—atherosclerosis	6.3e-06	4.75e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—LPL—atherosclerosis	6.28e-06	4.74e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—BGN—atherosclerosis	6.18e-06	4.66e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—GPX1—atherosclerosis	6.13e-06	4.63e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOA5—atherosclerosis	6.11e-06	4.61e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MMP9—atherosclerosis	6.08e-06	4.59e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—SCARB1—atherosclerosis	6.07e-06	4.58e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.05e-06	4.56e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOB—atherosclerosis	6.03e-06	4.55e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ABCA1—atherosclerosis	6.03e-06	4.55e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—NFKB1—atherosclerosis	6.02e-06	4.54e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—MTHFR—atherosclerosis	6e-06	4.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ABCA1—atherosclerosis	5.97e-06	4.51e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CD36—atherosclerosis	5.97e-06	4.5e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK8—atherosclerosis	5.91e-06	4.46e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	5.91e-06	4.46e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling by GPCR—AKT1—atherosclerosis	5.9e-06	4.45e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARA—atherosclerosis	5.89e-06	4.44e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	5.89e-06	4.44e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—VEGFA—atherosclerosis	5.87e-06	4.43e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GSTM1—atherosclerosis	5.87e-06	4.43e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—PTGS2—atherosclerosis	5.86e-06	4.42e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—STAT3—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Theophylline—PDE4C—Signaling Pathways—AKT1—atherosclerosis	5.82e-06	4.39e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—IL6—atherosclerosis	5.8e-06	4.38e-05	CbGpPWpGaD
Theophylline—HDAC2—Gene Expression—AKT1—atherosclerosis	5.76e-06	4.35e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—LPL—atherosclerosis	5.76e-06	4.35e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—IL6—atherosclerosis	5.75e-06	4.34e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HMGCR—atherosclerosis	5.73e-06	4.32e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AGT—atherosclerosis	5.7e-06	4.3e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALOX5—atherosclerosis	5.68e-06	4.29e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—MTHFR—atherosclerosis	5.66e-06	4.27e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—GPX1—atherosclerosis	5.62e-06	4.24e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOE—atherosclerosis	5.59e-06	4.21e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—IL6—atherosclerosis	5.58e-06	4.21e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—MAPK3—atherosclerosis	5.56e-06	4.19e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARA—atherosclerosis	5.55e-06	4.19e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—CAV1—atherosclerosis	5.53e-06	4.18e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—APOA1—atherosclerosis	5.52e-06	4.17e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—IL6—atherosclerosis	5.49e-06	4.14e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CD36—atherosclerosis	5.47e-06	4.13e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—VEGFA—atherosclerosis	5.46e-06	4.12e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—STAT3—atherosclerosis	5.41e-06	4.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—TGFB1—atherosclerosis	5.39e-06	4.07e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AGT—atherosclerosis	5.38e-06	4.06e-05	CbGpPWpGaD
Theophylline—HDAC2—Disease—AKT1—atherosclerosis	5.35e-06	4.04e-05	CbGpPWpGaD
Theophylline—ADORA2B—Signaling Pathways—AKT1—atherosclerosis	5.31e-06	4e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOE—atherosclerosis	5.27e-06	3.97e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—IL6—atherosclerosis	5.22e-06	3.94e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—CAV1—atherosclerosis	5.22e-06	3.94e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—APOA1—atherosclerosis	5.21e-06	3.93e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—MTHFR—atherosclerosis	5.19e-06	3.91e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—HMOX1—atherosclerosis	5.17e-06	3.9e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.17e-06	3.9e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—MAPK3—atherosclerosis	5.17e-06	3.9e-05	CbGpPWpGaD
Theophylline—PDE3B—Signaling Pathways—AKT1—atherosclerosis	5.15e-06	3.88e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—HMOX1—atherosclerosis	5.13e-06	3.87e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ABCA1—atherosclerosis	5.11e-06	3.85e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NAMPT—atherosclerosis	5.1e-06	3.85e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARA—atherosclerosis	5.09e-06	3.84e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—IL6—atherosclerosis	5.08e-06	3.83e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—LIPC—atherosclerosis	5.07e-06	3.82e-05	CbGpPWpGaD
Theophylline—PDE4D—Signaling Pathways—AKT1—atherosclerosis	5.06e-06	3.82e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PIK3CG—atherosclerosis	5.04e-06	3.8e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOC3—atherosclerosis	5.04e-06	3.8e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—TGFB1—atherosclerosis	5.01e-06	3.78e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—LDLR—atherosclerosis	5e-06	3.78e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOB—atherosclerosis	4.95e-06	3.74e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AGT—atherosclerosis	4.93e-06	3.72e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOB—atherosclerosis	4.91e-06	3.7e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—IL6—atherosclerosis	4.89e-06	3.69e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CETP—atherosclerosis	4.89e-06	3.69e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PPARG—atherosclerosis	4.87e-06	3.67e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—IL6—atherosclerosis	4.83e-06	3.65e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOE—atherosclerosis	4.83e-06	3.64e-05	CbGpPWpGaD
Theophylline—PDE4A—Signaling Pathways—AKT1—atherosclerosis	4.82e-06	3.64e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GSTM1—atherosclerosis	4.82e-06	3.64e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—CAV1—atherosclerosis	4.78e-06	3.61e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GSTM1—atherosclerosis	4.78e-06	3.6e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—APOA1—atherosclerosis	4.77e-06	3.6e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—INS—atherosclerosis	4.77e-06	3.6e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PIK3CG—atherosclerosis	4.75e-06	3.59e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—LPL—atherosclerosis	4.73e-06	3.57e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—LPL—atherosclerosis	4.69e-06	3.54e-05	CbGpPWpGaD
Theophylline—PDE3A—Signaling Pathways—AKT1—atherosclerosis	4.69e-06	3.54e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—SCARB1—atherosclerosis	4.68e-06	3.53e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—GPX1—atherosclerosis	4.61e-06	3.48e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PPARG—atherosclerosis	4.59e-06	3.46e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—GPX1—atherosclerosis	4.57e-06	3.45e-05	CbGpPWpGaD
Theophylline—ADORA1—Signaling Pathways—AKT1—atherosclerosis	4.51e-06	3.4e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—INS—atherosclerosis	4.5e-06	3.39e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CD36—atherosclerosis	4.49e-06	3.39e-05	CbGpPWpGaD
Theophylline—PDE4B—Signaling Pathways—AKT1—atherosclerosis	4.46e-06	3.36e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CD36—atherosclerosis	4.45e-06	3.36e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HMGCR—atherosclerosis	4.42e-06	3.34e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—HMOX1—atherosclerosis	4.38e-06	3.3e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—ALB—atherosclerosis	4.38e-06	3.3e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PIK3CG—atherosclerosis	4.36e-06	3.29e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—MTHFR—atherosclerosis	4.26e-06	3.21e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—MTHFR—atherosclerosis	4.22e-06	3.18e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PPARG—atherosclerosis	4.21e-06	3.17e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOB—atherosclerosis	4.2e-06	3.17e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—NOS3—atherosclerosis	4.19e-06	3.16e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARA—atherosclerosis	4.18e-06	3.15e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARA—atherosclerosis	4.14e-06	3.12e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—INS—atherosclerosis	4.13e-06	3.11e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—ALB—atherosclerosis	4.13e-06	3.11e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GSTM1—atherosclerosis	4.08e-06	3.08e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—IL6—atherosclerosis	4.06e-06	3.07e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AGT—atherosclerosis	4.05e-06	3.05e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AGT—atherosclerosis	4.01e-06	3.03e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—LPL—atherosclerosis	4.01e-06	3.02e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOE—atherosclerosis	3.96e-06	2.99e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—NOS3—atherosclerosis	3.95e-06	2.98e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ABCA1—atherosclerosis	3.94e-06	2.97e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOE—atherosclerosis	3.93e-06	2.97e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—CAV1—atherosclerosis	3.93e-06	2.96e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—APOA1—atherosclerosis	3.92e-06	2.96e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—GPX1—atherosclerosis	3.91e-06	2.95e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—CAV1—atherosclerosis	3.89e-06	2.94e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—APOA1—atherosclerosis	3.88e-06	2.93e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—PTGS2—atherosclerosis	3.83e-06	2.89e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CD36—atherosclerosis	3.81e-06	2.87e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—ALB—atherosclerosis	3.78e-06	2.85e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—IL6—atherosclerosis	3.78e-06	2.85e-05	CbGpPWpGaD
Theophylline—HDAC2—Signaling Pathways—AKT1—atherosclerosis	3.75e-06	2.83e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—NOS3—atherosclerosis	3.62e-06	2.73e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—PTGS2—atherosclerosis	3.61e-06	2.72e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—MTHFR—atherosclerosis	3.61e-06	2.72e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PIK3CG—atherosclerosis	3.58e-06	2.7e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PIK3CG—atherosclerosis	3.55e-06	2.68e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARA—atherosclerosis	3.54e-06	2.67e-05	CbGpPWpGaD
Theophylline—ADORA2A—Signaling Pathways—AKT1—atherosclerosis	3.48e-06	2.63e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PPARG—atherosclerosis	3.45e-06	2.61e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AGT—atherosclerosis	3.43e-06	2.59e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PPARG—atherosclerosis	3.42e-06	2.58e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—INS—atherosclerosis	3.39e-06	2.56e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—HMOX1—atherosclerosis	3.38e-06	2.55e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOE—atherosclerosis	3.36e-06	2.53e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—INS—atherosclerosis	3.36e-06	2.53e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—CAV1—atherosclerosis	3.33e-06	2.51e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—APOA1—atherosclerosis	3.32e-06	2.5e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—PTGS2—atherosclerosis	3.31e-06	2.5e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOB—atherosclerosis	3.24e-06	2.44e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GSTM1—atherosclerosis	3.15e-06	2.38e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—ALB—atherosclerosis	3.1e-06	2.34e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—LPL—atherosclerosis	3.09e-06	2.33e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—ALB—atherosclerosis	3.08e-06	2.32e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PIK3CG—atherosclerosis	3.03e-06	2.29e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—GPX1—atherosclerosis	3.02e-06	2.28e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—NOS3—atherosclerosis	2.97e-06	2.24e-05	CbGpPWpGaD
Theophylline—CYP1B1—Metabolism—AKT1—atherosclerosis	2.95e-06	2.22e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—NOS3—atherosclerosis	2.94e-06	2.22e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CD36—atherosclerosis	2.94e-06	2.22e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PPARG—atherosclerosis	2.93e-06	2.21e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—INS—atherosclerosis	2.87e-06	2.16e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—MTHFR—atherosclerosis	2.78e-06	2.1e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARA—atherosclerosis	2.73e-06	2.06e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—PTGS2—atherosclerosis	2.72e-06	2.05e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—PTGS2—atherosclerosis	2.69e-06	2.03e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AGT—atherosclerosis	2.65e-06	2e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—ALB—atherosclerosis	2.63e-06	1.98e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOE—atherosclerosis	2.59e-06	1.96e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—CAV1—atherosclerosis	2.57e-06	1.94e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—APOA1—atherosclerosis	2.56e-06	1.93e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—NOS3—atherosclerosis	2.52e-06	1.9e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	2.34e-06	1.76e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—PTGS2—atherosclerosis	2.3e-06	1.74e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PPARG—atherosclerosis	2.26e-06	1.7e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—INS—atherosclerosis	2.21e-06	1.67e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—ALB—atherosclerosis	2.03e-06	1.53e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—NOS3—atherosclerosis	1.94e-06	1.46e-05	CbGpPWpGaD
Theophylline—CYP2E1—Metabolism—AKT1—atherosclerosis	1.92e-06	1.45e-05	CbGpPWpGaD
Theophylline—CYP1A1—Metabolism—AKT1—atherosclerosis	1.81e-06	1.37e-05	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.78e-06	1.34e-05	CbGpPWpGaD
Theophylline—CYP2C8—Metabolism—AKT1—atherosclerosis	1.66e-06	1.25e-05	CbGpPWpGaD
Theophylline—CYP2D6—Metabolism—AKT1—atherosclerosis	1.37e-06	1.03e-05	CbGpPWpGaD
Theophylline—CYP2C9—Metabolism—AKT1—atherosclerosis	1.35e-06	1.02e-05	CbGpPWpGaD
Theophylline—CYP1A2—Metabolism—AKT1—atherosclerosis	1.16e-06	8.73e-06	CbGpPWpGaD
Theophylline—CYP3A4—Metabolism—AKT1—atherosclerosis	8.93e-07	6.73e-06	CbGpPWpGaD
